(PRWEB) January 09, 2013
The US Drug Watchdog is urging family members of a diabetic loved one, who has been diagnosed with bladder cancer to see if the diabetic was also using the diabetes drug called Actos. Some European countries have suspended sales of the diabetes drug called Actos, because of an elevated risk of bladder cancer. The US Drug Watchdog is now saying, "We need the help of loved ones, or family members to try and discover if a diabetic loved one, who was diagnosed with bladder cancer was also using the diabetes drug called Actos. Our big fear is many diabetics in the United States, who have been taking the diabetes drug called Actos, would never make the connection between their bladder cancer, and their use of the diabetes drug called Actos, so we are asking family members to help us out." If a family, or loved ones of a diabetic who has died from bladder can prove the diabetic was also using the diabetes drug called Actos they should contact the Johnson Law Group immediately at 1-800-996-9900. http://www.johnsonlawgroup.com/
According to the AP, "The FDA has issued a warning that Actos may be linked to an increased risk of bladder cancer. Meanwhile, both Germany and France have suspended sales of Actos. The Actos suspension became effective July 11, 2011. Actos (pioglitazone), along with another diabetes drug made by Takeda Pharmaceutical, Competact, came under fire in Europe after a study revealed an increased risk for bladder cancer among diabetes patients who were taking the medication." The US Drug Watchdog says, "We want any user of the diabetes medication called Actos, who then developed bladder cancer to call the Johnson Law Group at 1-800-996-9900. Time really is of the essence." http://www.johnsonlawgroup.com/
Case number 11cv2406 BEN BGS in the Federal District Court San Diego, CA.
Read the full story at http://www.prweb.com/releases/2013/1/prweb10287452.htm.
Copyright©2012 Vocus, Inc.
All rights reserved